inhaled beta-agonists MIGHT increase the risk of MI in COPD patients

June 2002

      There's new concern that inhaled beta-agonists MIGHT increase the risk of MI in COPD patients.

      Many COPD patients get albuterol or another inhaled beta-agonist to improve breathing.

      But new evidence suggests a higher risk of unstable angina and MI in patients using high doses of inhaled beta-agonists.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote